Lycke J. Moving from CSF to blood: monitoring disease activity in MS using serum neurofilament light protein. Abstract 282. ECTRIMS 2019, 11-13 sept 2019, Stockholm, Zweden.,Bjornevik K, et al. Serum neurofilament light chain as a presymptomatic biomarker in multiple sclerosis. Abstract 284. ECTRIMS 2019, 11-13 sept 2019, Stockholm, Zweden.,Bsteh G, et al. Serum neurofilament light chain levels correlate with peripapillary retinal nerve fibre layerthinning as measured by optical coherence tomography in multiple sclerosis. Abstract 285. ECTRIMS 2019, 11-13 sept 2019, Stockholm, Zweden.
36% van de geregistreerde klinische trials heeft geen gepubliceerde resultaten
mrt 2024